Literature DB >> 21311603

Are statin medications associated with lower urinary tract symptoms in men and women? Results from the Boston Area Community Health (BACH) Survey.

Susan A Hall1, Gretchen R Chiu, Carol L Link, William D Steers, Varant Kupelian, John B McKinlay.   

Abstract

PURPOSE: Statins may ameliorate lower urinary tract symptoms (LUTS) through anti-inflammatory or other pathways. We investigated the association between statin use and storage, voiding, and overall LUTS symptoms.
METHODS: The Boston Area Community Health Survey is an epidemiologic study of Boston, MA residents (2301 men; 3202 women) 30-79 years of age. LUTS, voiding, and storage symptoms were ascertained through an interviewer-administered questionnaire and defined as scores of greater than or equal to 8, greater than or equal to 5, and greater than or equal to 4, respectively, on relevant components of the American Urologic Association Symptom Index. Participants were included if they had a history of provider-diagnosed high cholesterol or recently used statin medications (n = 1346). Associations were estimated using odds ratios (ORs) and 95% confidence intervals (CI) from multivariate logistic regression.
RESULTS: In multivariate models, statin use had no association with LUTS (OR= 1.03, 95% CI: 0.70, 1.51) among women. No associations were observed for any LUTS among younger (<60) men, but among older (60+) men, we observed significant inverse associations for voiding (OR= 0.23, 95% CI: 0.08, 0.66), storage (OR = 0.24, 95% CI: 0.11, 0.56), and overall LUTS (OR = 0.15, 95% CI: 0.05, 0.44).
CONCLUSIONS: Our results suggest that use of statins is associated with a lower prevalence of urologic symptoms among older men but not among women or younger men.

Entities:  

Keywords:  HMG-CoA; epidemiology; statins; urination disorders

Mesh:

Substances:

Year:  2011        PMID: 21311603      PMCID: PMC3029018          DOI: 10.1016/j.annepidem.2010.09.002

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  23 in total

1.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

2.  A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly.

Authors:  C L Turvey; R B Wallace; R Herzog
Journal:  Int Psychogeriatr       Date:  1999-06       Impact factor: 3.878

3.  Manual for scoring socioeconomic status for research on health behavior.

Authors:  L W Green
Journal:  Public Health Rep       Date:  1970-09       Impact factor: 2.792

4.  The effect of bladder outflow obstruction on detrusor blood flow changes during the voiding cycle in conscious pigs.

Authors:  J E Greenland; A F Brading
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

5.  Focal hypoxia of the obstructed rabbit bladder wall correlates with intermediate decompensation.

Authors:  Robert M Levin; Laura J O'Connor; Robert E Leggett; Catherine Whitbeck; Paul Chichester
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

6.  Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism.

Authors:  Keira L Watts; Monica A Spiteri
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-08-06       Impact factor: 5.464

7.  Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men.

Authors:  J Kellogg Parsons; Jaclyn Bergstrom; Elizabeth Barrett-Connor
Journal:  BJU Int       Date:  2007-11-13       Impact factor: 5.588

Review 8.  Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment.

Authors:  A Ponholzer; S Madersbacher
Journal:  Int J Impot Res       Date:  2007-07-05       Impact factor: 2.896

9.  Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement.

Authors:  Ian W Mills; Anna Crossland; Anup Patel; Henrikas Ramonas
Journal:  Eur Urol       Date:  2007-02-20       Impact factor: 20.096

10.  The Lipid lowering and Onset of Renal Disease (LORD) Trial: a randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease.

Authors:  Robert G Fassett; Madeleine J Ball; Iain K Robertson; Dominic P Geraghty; Jeff S Coombes
Journal:  BMC Nephrol       Date:  2008-03-18       Impact factor: 2.388

View more
  13 in total

1.  Relationship Between Central Obesity, General Obesity, Overactive Bladder Syndrome and Urinary Incontinence Among Male and Female Patients Seeking Care for Their Lower Urinary Tract Symptoms.

Authors:  H Henry Lai; Margaret E Helmuth; Abigail R Smith; Jonathan B Wiseman; Brenda W Gillespie; Ziya Kirkali
Journal:  Urology       Date:  2018-10-28       Impact factor: 2.649

Review 2.  Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.

Authors:  Linda Vignozzi; Mauro Gacci; Mario Maggi
Journal:  Nat Rev Urol       Date:  2016-01-12       Impact factor: 14.432

3.  Are lower urinary tract symptoms associated with cardiovascular disease in the Dutch general population? Results from the Krimpen study.

Authors:  Inge I Bouwman; Marco H Blanker; Boris W V Schouten; Arthur M Bohnen; Rien J M Nijman; Wouter K van der Heide; J L H Ruud Bosch
Journal:  World J Urol       Date:  2014-09-25       Impact factor: 4.226

4.  Does hypercholesterolemia affect the relaxation of the detrusor smooth muscle in rats? In vitro and in vivo studies.

Authors:  Sibel Bayrak; Zeynep Dicle Balkanci; Bilge Pehlivanoğlu; İsmail Karabulut; Serkan Karaismailoğlu; Ayşen Erdem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-10-26       Impact factor: 3.000

5.  The effects of statins on benign prostatic hyperplasia in elderly patients with metabolic syndrome.

Authors:  Xiangyu Zhang; Xiaofang Zeng; Lini Dong; Xiaokun Zhao; Xiaobing Qu
Journal:  World J Urol       Date:  2015-04-08       Impact factor: 4.226

6.  Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.

Authors:  Emma H Allott; Ilona Csizmadi; Lauren E Howard; Roberto L Muller; Daniel M Moreira; Gerald L Andriole; Claus G Roehrborn; Stephen J Freedland
Journal:  BJU Int       Date:  2019-09-27       Impact factor: 5.588

7.  Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.

Authors:  Emma H Allott; Lauren E Howard; Adriana C Vidal; Daniel M Moreira; Ramiro Castro-Santamaria; Gerald L Andriole; Stephen J Freedland
Journal:  Cancer Prev Res (Phila)       Date:  2017-05-09

8.  The effect of hypercholesterolemia on carbachol-induced contractions of the detrusor smooth muscle in rats: increased role of L-type Ca2+ channels.

Authors:  Zeynep Dicle Balkanci; Bilge Pehlivanoğlu; Sibel Bayrak; Ismail Karabulut; Serkan Karaismailoğlu; Ayşen Erdem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-08-07       Impact factor: 3.000

9.  A prospective study of statin drug use and lower urinary tract symptoms in older men.

Authors:  Alison M Mondul; Edward Giovannucci; Elizabeth A Platz
Journal:  Am J Epidemiol       Date:  2013-07-11       Impact factor: 4.897

10.  The association of statin subgroups with lower urinary tract symptoms following a prostate biopsy.

Authors:  Hanan Goldberg; Faizan K Mohsin; Thenappan Chandrasekar; Christopher J D Wallis; Zachary Klaassen; Ardalan E Ahmad; Refik Saskin; Miran Kenk; Olli Saarela; Girish S Kulkarni; Shabbir M H Alibhai; Neil Fleshner
Journal:  Can Urol Assoc J       Date:  2022-05       Impact factor: 2.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.